Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122621706 | 12262170 | 6 | F | 20140919 | 20160815 | 20160413 | 20160822 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK048189 | GLAXOSMITHKLINE | 63.00 | YR | F | Y | 50.00000 | KG | 20160822 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122621706 | 12262170 | 1 | PS | HEPTODIN | LAMIVUDINE | 1 | Oral | 100 MG, QD | 30000 | MG | Y | 21003 | 100 | MG | TABLET | QD | |||
| 122621706 | 12262170 | 2 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 300 MG, QD | Y | A851221 | 0 | 300 | MG | TABLET | QD | ||||
| 122621706 | 12262170 | 3 | SS | ENTECAVIR. | ENTECAVIR | 1 | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122621706 | 12262170 | 1 | Hepatitis B |
| 122621706 | 12262170 | 2 | Hepatitis B |
| 122621706 | 12262170 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122621706 | 12262170 | OT |
| 122621706 | 12262170 | DE |
| 122621706 | 12262170 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122621706 | 12262170 | Abdominal distension | |
| 122621706 | 12262170 | Asthenia | |
| 122621706 | 12262170 | Back pain | |
| 122621706 | 12262170 | Blood creatine phosphokinase increased | |
| 122621706 | 12262170 | Death | |
| 122621706 | 12262170 | Decreased appetite | |
| 122621706 | 12262170 | Drug resistance | |
| 122621706 | 12262170 | Face oedema | |
| 122621706 | 12262170 | Gastrointestinal haemorrhage | |
| 122621706 | 12262170 | Haematemesis | |
| 122621706 | 12262170 | Hepatic function abnormal | |
| 122621706 | 12262170 | Jaundice | |
| 122621706 | 12262170 | Melaena | |
| 122621706 | 12262170 | Mental disorder | |
| 122621706 | 12262170 | Ocular icterus | |
| 122621706 | 12262170 | Oedema peripheral | |
| 122621706 | 12262170 | Pain | |
| 122621706 | 12262170 | Pain in extremity | |
| 122621706 | 12262170 | Suicidal ideation | |
| 122621706 | 12262170 | Vomiting | |
| 122621706 | 12262170 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122621706 | 12262170 | 1 | 2014 | 201604 | 0 | |
| 122621706 | 12262170 | 2 | 201604 | 201606 | 0 | |
| 122621706 | 12262170 | 3 | 201604 | 0 |